Hostname: page-component-5c6d5d7d68-wbk2r Total loading time: 0 Render date: 2024-08-15T06:18:16.603Z Has data issue: false hasContentIssue false
  • English
  • Français

Aspirin in pregnancy

Published online by Cambridge University Press:  10 October 2008

Henk A Bremer  and
Henk CS Wallenburg
Henk A Bremer
Affiliation:
Institute of Obstetrics and Gynaecology, Erasmus University School of Medicine and Health Sciences, Rotterdam, The Netherlands
Henk CS Wallenburg*
Affiliation:
Institute of Obstetrics and Gynaecology, Erasmus University School of Medicine and Health Sciences, Rotterdam, The Netherlands
*
Professor Henk CS Wallenburg, Institute of Obstetrics and Gynaecology, EUR EE 2283, PO Box 1738, 3000 DR Rotterdam, The Netherlands.
Get access Rights & Permissions [Opens in a new window]

Extract

Aspirin, acetylsalicylic acid, is the most frequently consumed drug in pregnancy, taken mostly without a prescription because of headache or a minor ailment. Numerous preparations containing acetylsalicylic acid are freely available over the counter under a variety of proprietary names, and in many cases pregnant women and their doctors may be unaware that aspirin is being taken.

Type
Articles
Information
Fetal and Maternal Medicine Review , Volume 4 , Issue 2 , July 1992 , pp. 37 - 57
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Corby, DG. Aspirin in pregnancy: maternal and fetal effects. Pediatrics 1978; 62(suppl): 930–37.Google ScholarPubMed
2Streissguth, AP, Treder, RP, Barr, HM, Shepard, TH, Bleyer, WA, Sampson, PD. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology 1987; 35: 211–19.CrossRefGoogle ScholarPubMed
3Werler, MM, Mitchell, AA, Shapiro, S. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 1989; 321: 1639–42.CrossRefGoogle ScholarPubMed
4Bremer, HA, Jharap, MG, Van Kemenade, JEM, Wallenburg, HCS. Aspirin in pregnancy: a change in attitude (unpublished observations).Google Scholar
5Weissmann, G. Aspirin. Sci Am 1991; January: 58–64.Google Scholar
6Friend, DG. Aspirin: the unique drug. Arch Surg 1974; 108: 765–69.CrossRefGoogle ScholarPubMed
7Vane, JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 1971; 231: 232–35.CrossRefGoogle ScholarPubMed
8Moncada, S, Higgs, EA. Introduction to the mode of action of aspirin. In: Hallam, J, Goldman, L, Fryers, GR eds. Aspirin symposium 1983. London: Royal Society of Medicine Services, 1984: 1–9.Google Scholar
9Walsh, SW. Physiology of low-dose aspirin therapy for the prevention of pre-eclampsia. Semin Perinatol 1990; 14: 152–70.Google Scholar
10FitzGerald, GA, Sherry, S. Pharmacology and pharmacokinetics of platelet-active drugs under clinical investigation. In: Oates, JA ed. Advances in prostaglandin, thromboxane and leucotriences research, volume 10. New York: Raven Press, 1982: 107–72.Google Scholar
11Oates, JA, FitzGerald, GA, Brand, RA, Jackson, EK, Knapp, HR, Roberts, LJ. Clinical implications of prostaglandin and thromboxane A2 formation. N Engl J Med 1988; 319: 689–98.CrossRefGoogle ScholarPubMed
12Stuart, MJ, Murphy, S, Oski, FA. A simple nonradioisotope technic for determination of platelet life-span. N Engl J Med 1975; 292: 1310–13.CrossRefGoogle ScholarPubMed
13Wallenburg, HCS, Van, Kessel PH. Platelet lifespan in normal pregnancy as determined by a nonradioisotopic technique. Br J Obstet Gynaecol 1978; 85: 33–36.CrossRefGoogle ScholarPubMed
14FitzGerald, GA, Oates, JA, Hawiger, J et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983; 71: 676–88.CrossRefGoogle ScholarPubMed
15Jaffe, EA, Weksler, BB. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest 1979; 63: 532–35.CrossRefGoogle ScholarPubMed
16Kelton, JG. Antiplatelet agents: rationale and results. Clin Hematol 1983; 12: 311–54.CrossRefGoogle ScholarPubMed
17Buchanan, MR, Butt, RW, Hirsh, J, Markham, BA, Nazir, DJ. Role of lipoxygenase metabolism in platelet function: effect of aspirin and salicylate. Prostaglandins Leukotrienes Med 1986; 21: 157–68.CrossRefGoogle ScholarPubMed
18Wallenburg, HCS. Changes in the coagulation system and platelets in pregnancy-induced hypertension and pre-eclampsia. In: Sharp, F, Symonds, EM eds. Hypertension in pregnancy. Ithaca: Perinatology Press, 1987: 227–48.Google Scholar
19Tschopp, TB. Aspirin inhibits platelet aggregation on, but not adhesion to, collagen fibrils: an assessment of platelet adhesion and deposited platelet mass by morphometry and 51Cr-labelling. Thromb Res 1977; 11: 619–32.CrossRefGoogle ScholarPubMed
20Collins, R, Wallenburg, HCS. Pharmacological prevention and treatment of hypertensive disorders in pregnancy. In: Chalmers, I, Enkin, M, Keirse, MJNC eds. Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989: 512–33.Google Scholar
21Peto, R, Gray, R, Collins, R et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J 1988; 296: 313–16.CrossRefGoogle ScholarPubMed
22The RISC group. Risk of myocardial infarction and death during treatment with low does aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827–30.CrossRefGoogle Scholar
23Mortensen, ME, Rennebohm, RM. Clinical pharmacology and use of nonsteroidal antiinflammatory drugs. Pediatr Clin North Am 1989; 36: 1113–39.CrossRefGoogle Scholar
24Insel, PA. Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: GoodmanGilman, A, Rall, TW, Nies, AS, Taylor, P eds. Goodman & Gilman’s The pharmacological basis of therapeutics. Elmsford: Pergamon Press, 1990: 638–81.Google Scholar
25Hytten, FE. The alimentary system. In: Hytten, F, Chamberlain, G eds. Clinical physiology in obstetrics. Oxford: Blackwell, 1991: 137–49.Google Scholar
26Rowland, M, Riegelman, S. Pharmacokinetics of acetyl-salicylic acid after intravenous administration in man. J Pharm Sci 1968; 57: 1313–19.CrossRefGoogle Scholar
27Patrono, C. Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back. Trends Pharmacol Sci 1989; 10: 453–58.CrossRefGoogle ScholarPubMed
28Needs, CJ, Brooks, PM. Anti-rheumatic medication during lactation. Br J Rheumatol 1985; 24: 291–97.CrossRefGoogle Scholar
29Jacobson, RL, Brewer, A, Eis, A, Siddiqi, TA, Myatt, L. Transfer of aspirin across the perfused human placental cotyledon. Am J Obstet Gynecol 1991; 165: 939–44.CrossRefGoogle ScholarPubMed
30Rudolph, AM. Effects of aspirin and acetaminophen in pregnancy and in the newborn. Arch Intern Med 1981; 141: 353–63.CrossRefGoogle ScholarPubMed
31Levy, G, Garrettson, LK. Kinetics of salicylate elimination by newborn infants of mothers who ingested aspirin before delivery. Pediatrics 1974; 53: 201–10.CrossRefGoogle ScholarPubMed
32Ylikorkala, O, Mäkilä, U-M, Kääpä, P, Viinikka, L. Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans. Am J Obstet Gynecol 1986; 155: 345–49.CrossRefGoogle ScholarPubMed
33Sibai, BM, Mirro, R, Chesney, CM, Leffler, C. Low-dose aspirin in pregnancy. Obstet Gynecol 1989; 74: 551–57.Google ScholarPubMed
34Ritter, JM, Farquhar, C, Rodin, A, Thom, MH. Low dose aspirin treatment in late pregnancy differentially inhibits cyclo-oxygenase in maternal platelets. Prostaglandins 1987; 34: 717–22.CrossRefGoogle ScholarPubMed
35Benigni, A, Gregorini, G, Frusca, T et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–62.CrossRefGoogle ScholarPubMed
36Wallenburg, HCS. Maternal haemodynamics in pregnancy. Fetal Med Rev 1990; 2: 45–66.CrossRefGoogle Scholar
37Wallenburg, HCS. Prevention of hypertensive disorders in pregnancy. Clin Exp Hypertens 1988; B7: 121–37.Google Scholar
38Moncada, S, Vane, JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev 1979; 30: 293–331.Google Scholar
39Noort, WA, Keirse, MJNC. Prostacyclin versus thromboxane metabolite excretion: changes in pregnancy and labour. Eur J Obstet Gynecol Reprod Biol 1990; 35: 15–21.CrossRefGoogle Scholar
40Ylikorkala, O, Mäkilä, U-M. Prostacyclin and thromboxane in gynecology and pregnancy. Am J Obstet Gynecol 1985; 152: 318–29.CrossRefGoogle Scholar
41Wallenburg, HCS, Dekker, GA, Makovitz, JW, Rotmans, N. Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women. Am J Obstet Gynecol 1991; 164: 1169–73.CrossRefGoogle ScholarPubMed
42Redman, CWG. The fetal allograft. Fetal Med Rev 1990; 2: 21–43.CrossRefGoogle Scholar
43Friedman, SA. Pre-eclampsia: a review of the role of prostaglandins. Obstet Gynecol 1988; 71: 122–37.Google ScholarPubMed
44Wallenburg, HCS. Placental insufficiency: pathophysiology and therapeutic approaches. Triangle 1991; 29: 171–79.Google Scholar
45Scott, JR, Rote, NS, Branch, DW. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987; 70: 645–56.Google ScholarPubMed
46Wallenburg, HCS, Rotmans, P, van, Kessel PH. Platelet function and dynamics in pregnancies with insufficient fetal growth. In: Sakamoto, S, Tojo, S, Nakayama, T eds. Proceedings IX World Congress of Gynecology and Obstetrics. Amsterdam: Excerpta Medica, 1980: 184–89.Google Scholar
47Wallenburg, HCS. Prostaglandins and the maternal placental circulation: review and perspectives. Biol Res Pregnancy 1981; 2: 15–22.Google ScholarPubMed
48Wallenburg, HCS, Rotmans, N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987; 157: 1230–35.CrossRefGoogle ScholarPubMed
49Pedersen, AK, FitzGerald, GA. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclo-oxygenase. N Engl J Med 1984; 311: 1206–11.CrossRefGoogle Scholar
50Hanley, SP, Bevan, J, Cockbill, SR, Heptinstall, S. A regimen for low-dose aspirin? Br Med J 1982; 285: 1299–1302.CrossRefGoogle ScholarPubMed
51Clarke, RJ, Mayo, G, Price, P, FitzGerald, GA. Suppression of thromboxane A2 but not of systematic prostacyclin by controlled-release aspirin. N Engl J Med 1991; 325: 1137–41.CrossRefGoogle ScholarPubMed
52Goldstein, AL. Aspirin and immunity: modulation of lymphokine production. In: Fryers, G ed.Aspirin towards 2000. London: Royal society of medicine Services, 1990:33–38.Google Scholar
53Kerise, MJNC, Mitchell, MD, Turnbull, AC. Changes in prostaglandin F and 13,14-dihydro-15-keto-prostaglandin F concentrations in amniotic fluid at the onset of and during labour. Br J Obstet Gynaecol 1977; 84: 743–46.CrossRefGoogle Scholar
54Keirse, MJNC, Chalmers, I. Methods for including labour. In: Chalmers, I, Enkin, M, Keirse, MJNC eds. Effective care in pregnancy and childbirth, Oxford: Oxford University Press, 1989: 1057–79.Google Scholar
55Quaas, L, Göppinger, A, Zahradnik, HP. The effect of acetylsalicylic acid and indomethacin on the catecholamine-and-oxytocin-induced contractility and prostaglandin (6-keto-PGF1α, PGF2α)-production of human pregnant myometrial strips. Prostaglandins 1987; 34: 257–69.CrossRefGoogle Scholar
56Lewis, RB, Schulman, JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973; ii: 1159–61.CrossRefGoogle Scholar
57Dornhöfer, W, Mosler, KH. Prostaglandine und β-Stimulatoren. In: Jung, H, Klöck, FK eds. Th 1165a (Partusisten) bei der Behandlung in der Geburtshilfe und Perinatologie. Stuttgart: Thieme, 1975: 196–202.Google Scholar
58Wolff, F, Berg, R, Bolte, A. Klinische Untersuchungen zur wehenhemmenden Wirkung der Azetylsalizylsäure (ASS) und ihrer Nebenwirkungen. Geburtshilfe Frauenheilkd 1981; 41: 96–100.CrossRefGoogle Scholar
59Niebyl, JR, Blake, DA, White, RD et al. The inhibition of premature labour with indomethacin. Am J Obstet Gynecol 1980; 136: 1014–19.CrossRefGoogle ScholarPubMed
60Niebyl, JR, Witter, FR. Neonatal outcome after indomethacin treatment for premature labour. Am J Obstet Gynecol 1986; 155: 747–49.CrossRefGoogle Scholar
61Crandon, AJ, Isherwood, DM. Effect of aspirin on incidence of pre-eclampsia. Lancet 1979; i: 1356.CrossRefGoogle Scholar
62Goodlin, RC, Haesslein, HO, Fleming, J. Aspirin for the treatment of recurrent toxaemia. Lancet 1978; ii: 51.CrossRefGoogle Scholar
63Jespersen, J. Disseminated intravascular coagulation in toxemia of pregnancy. Correction of the decreased platelet counts and raised levels of serum uric acid and fibrin(ogen) degradation products by aspirin. Thromb Res 1980; 17: 743–46.CrossRefGoogle ScholarPubMed
64Goodlin, RC. Correction of pregnancy-related thrombocytopenia with aspirin without improvement in fetal outcome. Am J Obstet Gynecol 1983; 146: 862–65.CrossRefGoogle ScholarPubMed
65Beaufils, M, Uzan, S, Donsimoni, R, Colau, JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; i: 840–42.CrossRefGoogle Scholar
66Wallenburg, HCS, Dekker, GA, Makovitz, JW, Rotmans, P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; i: 1–3.CrossRefGoogle Scholar
67Schiff, E, Peleg, E, Goldenberg, M et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351–56.CrossRefGoogle ScholarPubMed
68McParland, P, Pearce, JM, Chamberlain, GVP. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990; i: 1552–55.CrossRefGoogle Scholar
69Uzan, S, Beaufils, M, Breart, G, Bazin, B, Capitant, C, Paris, J. Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 1991; 337: 1427–31.CrossRefGoogle ScholarPubMed
70Chalmers, I, Hetherington, J, Elbourne, D, Keirse, MJNC, Enkin, M. Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth. In: Chalmers, I, Enkin, M, Keirse, MJNC eds. Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989: 39–65.Google Scholar
71Imperiale, TF, Petrulis, AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. J A M A 1991; 266: 260–64.CrossRefGoogle ScholarPubMed
72Trudinger, BJ, Cook, CM, Thompson, RS, Giles, WB, Connelly, A. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. Am J Obstet Gynecol 1988; 159: 681–85.CrossRefGoogle ScholarPubMed
73Wallenburg, HCS, Rotmans, N. Prophylactic low-dose aspirin and dipyridamole in pregnancy. Lancet 1988; i: 939.CrossRefGoogle Scholar
74Elder, MG, De Swiet, M, Robertson, A, Elder, MA, Flloyd, E, Hawkins, DF. Low-dose aspirin in pregnancy. Lancet 1988; i: 410.CrossRefGoogle Scholar
75Trudinger, BJ, Cook, CM, Giles, WB, Connelly, AJ, Thompson, RS. Low-dose aspirin and twin pregnancy. Lancet 1989; ii: 1214.CrossRefGoogle Scholar
76Verloove-Vanhorick, SP, Verwey, RA, Brand, R, Bennebroek Gravenhorst, J, Keirse, MJNC, Ruys, JH. Neonatal mortality risk in relation to gestational age and birthweight. Lancet 1986; i 55–57.CrossRefGoogle Scholar
77Schiff, E, Barkai, G, Ben-Baruch, G, Mashiach, S. Low-dose aspirin dose not influence the clinical course of women with mild pregnancy-induced hypertension. Obstet Gynecol 1990; 76: 742–44.CrossRefGoogle Scholar
78Spitz, B, Magness, RR, Cox, SM et al. Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II. Am J Obstet Gynecol 1988; 159: 1035–43.CrossRefGoogle ScholarPubMed
79Sanchez-Ramos, L, O’Sullivan, MJ, Garrido-Calderon, J. Effect of low -dose aspirin on angiotensin II pressor response in human pregnancy. Am J Obstet Gynecol 1987; 156: 193–94.CrossRefGoogle ScholarPubMed
80Everett, RB, Worley, RJ, MacDonald, PC, Gant, NF. Effect of prostaglandin synthetase inhibitors on response to angiotensin II in human pregnancy. J Clin Endocrinol Metab 1978; 46: 1007–10.CrossRefGoogle ScholarPubMed
81Reece, EA, Gabrielli, S, Cullen, MT, Zheng, X, Hobbins, JC, Harris, EN. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990; 163: 162–69.CrossRefGoogle ScholarPubMed
82Dombroski, RA. Autoimmune disease in pregnancy. Med Clin North Am 1989; 73: 605–12.CrossRefGoogle ScholarPubMed
83Brown, HL. Antiphospholipid antibodies and recurrent pregnancy loss. Clin Obstet Gynecol 1991; 34: 17–26.CrossRefGoogle ScholarPubMed
84Branch, DW, Scott, JR, Kochenour, NK, Hershgold, E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322–26.CrossRefGoogle ScholarPubMed
85Carreras, LO, Vermylen, JG. ‘Lupus’ anticoagulant and thrombosis – possible role of inhibition of prostacyclin formation. Thromb Haemost 1982; 48: 38–40.Google ScholarPubMed
86Lubbe, WF, Palmer, SJ, Butler, WS, Liggins, GC. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983; i: 1361–63.CrossRefGoogle Scholar
87Lubbe, WF, Liggins, GC. Role of lupus anticoagulant and autoimmunity in recurrent pregnancy loss. Semin Reprod Endocrinol 1988; 6: 181–90.CrossRefGoogle Scholar
88Norberg, R, Nived, O, Sturfeld, G, Unander, M, Arfors, L. Anticardiolipin and complement activation: relation to clinical symptoms. J Rheumatol, 1987; 14: 149–53.Google ScholarPubMed
89Farquharson, RG, Pearson, JF, John, L. Lupus anticoagulant and pregnancy management. Lancet 1984; ii: 228–29.CrossRefGoogle Scholar
90Crowshaw, K. Introduction to the side-effects of aspirin. In: Hallam, J, Goldman, C, Fryers, GR eds. Aspirin symposium 1983. London: Royal Society of Medicine Services, 1984: 27–31.Google Scholar
91De Swiet, M, Fryers, G. Review: the use of aspirin in pregnancy. J Obstet Gynaecol 1990; 10: 467–82.CrossRefGoogle Scholar
92Quick, AJ. Salicylates and bleeding: the aspirin tolerance test. Am J Med Sci 1966; 252:265–69.CrossRefGoogle ScholarPubMed
93Weiss, HJ, Aledort, LM, Kochwa, S. The effects of salicylates on the hemostatic properties in man. J Clin Invest 1968;47: 2169–80.CrossRefGoogle ScholarPubMed
94Mielke, CH Jr. Influence of aspirin on platelets and the bleeding time. Am J Med 1983; 74: 72–78.CrossRefGoogle ScholarPubMed
95Frith, PA, Warlow, CP. A study of bleeding time in 120 long term aspirin trial patients. Thromb Res 1988; 49: 463–70.CrossRefGoogle ScholarPubMed
96Rodgers, RPC, Levin, J. A critical review of the bleeding time. Semin Thromb Hemost 1990; 16: 1–20.CrossRefGoogle ScholarPubMed
97ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349–60.Google Scholar
98Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study. N Engl J Med 1989; 321: 129–35.CrossRefGoogle Scholar
99Taggart, DP, Siddiqui, A, Wheatley, DJ. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg 1990; 50: 425–28.CrossRefGoogle ScholarPubMed
100Prichard, PJ, Kitchingman, GK, Walt, RP, Daneshmend, TK, Hawkey, CJ. Human gastric mucosal bleeding induced by low-dose aspirin but not by warfarin. Br Med J 1989; 321: 129–35.Google Scholar
101Baker, PN, Williamson, JG, Louden, KA. Possible low-dose aspirin-induced gastropathy. Lancet 1992; 339: 550CrossRefGoogle ScholarPubMed
102Collins, E, Turner, G. Maternal effects of regular salicylate ingestion in pregnancy. Lancet 1975; ii: 335–38.CrossRefGoogle Scholar
103Stuart, MJ, Gross, SJ, Elrad, H, Graeber, JE. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engl J Med 1982; 307: 909–12.CrossRefGoogle ScholarPubMed
104Jankowski, A, Skubicki, S, Wichlinski, LM, Szymanski, W. Clinical-pharmacokinetic investigations of acetylsalicylic acid in cases of imminent premature delivery. J Clin Hosp Pharm 1985; 10: 361–66.Google ScholarPubMed
105Nuñez, L, Larrea, JL, Gil Aguado, M, Reque, JA, Matorras, R, Minguez, JA. Pregnancy in 20 patients with bioprosthetic valve replacement. Chest 1983; 84: 26–28.CrossRefGoogle ScholarPubMed
106 Brent et al. cited from Reference 91.Google Scholar
107Macdonald, R. Aspirin and extradural blocks [Editorial]. Br J Anaesth 1991; 66: 1–3.CrossRefGoogle ScholarPubMed
108O’Sullivan, G. Regional anesthesia and aspirin. Anesthesiology 1990; 73: 359.CrossRefGoogle ScholarPubMed
109Waltman, R, Tricomi, V, Palav, A. Aspirin and indomethacin: effect on instillation/abortion time of mid-trimester hypertonic saline induced abortion. Prostaglandins 1973; 3: 47–59.CrossRefGoogle ScholarPubMed
110Moggian, G, Palombi, L, Tamburini, E, Visona, E. Clinical trial of a new analgesic (lysine acetylsalicylate) in labor. Minerva Ginecol 1976; 28: 39–58.Google ScholarPubMed
111Brancadoro, V, Somma, A, Tinelli, F, Capasso, A, Cuorolo, R. Labor analgesia with lysine-acetylsalicylate. Evaluation of various respiratory, circulatory and hematological parameters in mothers and newborn infants. Minerva Ginecol 1978; 30: 553–64.Google Scholar
112Ventura, S, Catalano, S, Cianci, A. Delivery under general anesthesia with the sequence of althesin and lysine acetylsalicylate: a clinical contribution. Minerva Anestesiol 1980; 46: 305–10.Google ScholarPubMed
113Warkany, J, Takacs, E. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol 1959; 35: 315–31.Google ScholarPubMed
114Anonymous. Salicylates and malformations. Br Med J 1970; 1: 642–43.CrossRefGoogle Scholar
115Richards, IDG. Congenital malformations and environmental influences in pregnancy Br J Prev Soc Med 1969; 23: 218–25.Google ScholarPubMed
116Nelson, MM, Forfar, JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J 1971; 1: 523–27.CrossRefGoogle ScholarPubMed
117Saxen, I. Associations between oral clefts and drugs taken during pregnancy. Int J Epiodemiol 1975; 4: 37–44.CrossRefGoogle ScholarPubMed
118Zierler, S, Rothman, KJ. Congenital heart disease in relation to maternal use of bendectin and other drugs in early pregnancy. N Engl J Med 1985; 313: 347–52.CrossRefGoogle ScholarPubMed
119Agapitos, M, Georgiou-Theodoropoulou, M, Koutselinis, A, Papacharalampus, N. Cyclopia and maternal ingestion of salicylates. Pediatr Pathol 1986; 6: 309–10.CrossRefGoogle ScholarPubMed
120Benawra, R, Mangurten, HH, Duffell, DR. Cyclopia and other anomalies following maternal ingestion of salicylates. J Pediatr 1980; 96: 1069–71.CrossRefGoogle ScholarPubMed
121McNiel, JR. The possible teratogenic effect of salicylates on the developing fetus. Clin Pediatr 1973; 12: 347–50.CrossRefGoogle ScholarPubMed
122Sayli, BS, Asmaz, A, Yemisci, B. Consanguinity, aspirin, and phocomelia [correspondence]. Lancet 1966; i: 876.CrossRefGoogle Scholar
123Bove, KE, Bhathena, D, Wyatt, RJ, Lucas, BA, Holland, NH. Diffuse metanephric adenoma after in utero aspirin intoxication. Arch Pathol Lab Med 1979; 103: 187–90.Google ScholarPubMed
124Hayden, GF, Kramer, MS, Horwitz, RI. The case-control study: a practical guide for the clinician. JAMA 1982; 247: 326–31.CrossRefGoogle Scholar
125Slone, D, Siskind, V, Heinonen, OP, Monson, RR, Kaufman, DW, Shapiro, S. Aspirin and congenital malformations. Lancet 1976; i: 1373–75.CrossRefGoogle Scholar
126Crombie, DL, Pinsent, RJFH, Slater, BC, Fleming, D, Cross, KW. Teratogenic drugs-RCGP survey. Br Med J 1970; 4: 178–79.CrossRefGoogle ScholarPubMed
127Turner, G, Collins, E. Fetal effects of regular salicylate ingestion in pregnancy. Lancet 1975; ii: 338–39.CrossRefGoogle Scholar
128Ts’ao, C, Green, D, Schultz, K. Function and ultrastructure of platelets of neonates: enhanced ristocetin aggregation of neonatal platelets. Br J Haematol 1976; 32: 225–33.CrossRefGoogle ScholarPubMed
129Gibson, B. Neonatal haemostasis. Arch Dis Child 1989; 64: 503–506.CrossRefGoogle ScholarPubMed
130Jackson, AV. Toxic effects of salicylate on the fetus and mother. J Pathol Bact 1948; 60: 587–93.CrossRefGoogle Scholar
131Haslam, RR, Ekert, H, Gillam, MB. Hemorrhage in a neonate possibly due to maternal ingestion of salicylate. J Pediatr 1974; 84: 556–57.CrossRefGoogle Scholar
132Haslam, RH. Neonatal purpura secondary to maternal salicylism [correspondence]. J Pediatr 1975; 86: 653.CrossRefGoogle ScholarPubMed
133Bleyer, WA, Breckenridge, RT. Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA 1970; 213: 2049–53.CrossRefGoogle ScholarPubMed
134Rumack, CM, Guggenheim, MA, Rumack, BH, Peterson, RG, Johnson, ML, Braithwaite, WR. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 1981; 58: 52–56S.Google ScholarPubMed
135Soller, RW, Stander, H. Maternal drug exposure and perinatal intracranial hemorrhage. Obstet Gynecol 1981; 58: 735–37.Google ScholarPubMed
136Corby, DG. Editorial. Obstet Gynecol 1981; 58: 737–40.Google Scholar
137Van Eyck, J. The ductus arteriosus. Fetal Med Rev 1990; 2: 207–23.CrossRefGoogle Scholar
138Coceani, F, Olley, PM. The control of cardiovascular shunts in the fetal and perinatal period. Can J Physiol Pharmacol 1988; 66: 1129–34.CrossRefGoogle ScholarPubMed
139Cassin, S, Tod, M, Philips, J, Frisinger, J, Jordan, J, Gibbs, C. Effects of prostaglandin D2 in perinatal circulation. Am J Physiol 1981; 240: 755–60.Google ScholarPubMed
140Heymann, MA. Fetal and neonatal circulation. In: Kretchmer, N, Quilligan, EJ, Johnson, JD eds. Prenatal and perinatal biology and medicine. Chur: Harwood, 1989: 227–59.Google Scholar
141Cassin, S. Role of prostaglandins, thromboxanes, and leukotrienes in the control of the pulmonary circulation in the fetus and newborn. Semin Perinatol 1987; 11: 53–63.Google ScholarPubMed
142Gersony, WM, Peckham, GJ, Ellison, RC, Miettinen, OS, Nadas, AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102: 895–906.CrossRefGoogle ScholarPubMed
143Levin, DL, Millo, LJ, Parkey, M, Garriott, J, Campbell, W. Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe. J Pediatr 1979; 94: 647–50.CrossRefGoogle Scholar
144Levin, DL. Effect of inhibition of prostaglandin synthesis on fetal development, oxygenation, and the fetal circulation. Semin Perinatol 1980; 4: 35–44.Google ScholarPubMed
145Heymann, MA, Rudolph, AM. Effect of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Circ Res 1976; 38: 418–22.CrossRefGoogle ScholarPubMed
146Sharpe, GL, Larsson, KS, Thalme, B. Studies on the closure of the ductus arteriosus. XII: In utero effects of indomethacin and sodium salicylate in rats and rabbits. Prostaglandins 1975; 9: 585–96.CrossRefGoogle ScholarPubMed
147Sharpe, GL, Thalme, B, Larsson, KS. Studies on closure of the ductus arteriosus. XI: Ductal closure in utero by a prostaglandin synthetase inhibition. Prostaglandins 1974; 8: 363–68.CrossRefGoogle Scholar
148Levin, DL, Mills, LJ, Weinberg, AG et al. Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus: a possible mechanism for persistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infant. Circulation 1979; 60: 360–64.CrossRefGoogle ScholarPubMed
149Arcilla, RA, Thilenius, OG, Ranniger, K. Congestive heart failure from suspected ductal closure in utero. J Pediatr 1969; 75: 74–78.CrossRefGoogle ScholarPubMed
150Levin, DL, Fixler, DE, Morriss, FC, Tyson, J. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr 1978; 92: 478–83.CrossRefGoogle ScholarPubMed
151Perkin, RM, Levin, DL, Clark, R. Serum salicylate levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1980; 96: 721–26.CrossRefGoogle ScholarPubMed
152Cunningham, MD, Ellison, RC, Zierler, S, Kanto, WP, Miettinen, OS, Nadas, AS. Perinatal risk assessment for patent ductus arteriosus in premature infants. Obstet Gynecol 1986; 68: 41–45.Google ScholarPubMed
153Gittenberger-de Groot, AC, Van Ertbruggen, I, Moulaert, AJMG et al. The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr 1980; 96: 88–91.CrossRefGoogle ScholarPubMed
154Moise, KJ, Huhta, JC, Sharif, DS. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 1988; 319: 327–31.CrossRefGoogle ScholarPubMed
155Butcher, RE, Vorhees, CV, Kimmel, CA. Learning impairment from maternal salicylate treatment in rats. Nature (New Biol) 1972; 236: 211–12.CrossRefGoogle ScholarPubMed
156Voorhees, CV, Klein, KL, Scott, WJ. Aspirin-induced psychoteratogenesis in rats as a function of embryonic age. Teratogen Carcinogen Mutagen 1982; 2: 77–84.3.0.CO;2-C>CrossRefGoogle Scholar
157Klebanoff, MA, Berendes, HW. Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age. Teratology 1988; 37: 249–55.CrossRefGoogle ScholarPubMed
158Reye, RDK, Morgan, G, Baral, J. Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet 1963; ii: 749–52.CrossRefGoogle Scholar
159Sullivan-Bolyai, JZ, Corey, L. Epidemiology of Reye syndrome. Epidemiol Rev 1981; 3: 1–26.CrossRefGoogle ScholarPubMed
160Hurwitz, ES. Reye’s syndrome. Epidemiol Rev 1989; 11: 249–53.CrossRefGoogle ScholarPubMed
161 Notes and News. Reye’s syndrome and the giving of aspirin to children. Lancet 1986; i: 1396.Google Scholar
162Papageorgiou, A, Wiglesworth, FW, Schiff, D, Stern, L. Reye’s syndrome in a newborn infant. Can Med Assoc J 1973; 109: 717–20.Google Scholar
163Harris, HB, Vogler, LB, Cassady, G. Reye’s syndrome in a neonate. South Med J 1976; 69: 1511–12.CrossRefGoogle ScholarPubMed
164Schrager, GO. PDAs, Prostaglandins and RLF [Correspondence]. Pediatrics 1978; 62: 860–61.CrossRefGoogle ScholarPubMed
165Wallenburg, HCS, Rotmans, N. Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy [Correspondence]. Am J Obstet Gynecol 1989; 160: 763–64.CrossRefGoogle Scholar